scholarly journals Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction

Nutrients ◽  
2018 ◽  
Vol 10 (11) ◽  
pp. 1793 ◽  
Author(s):  
Marcin Krawczyk ◽  
Dominika Maciejewska ◽  
Karina Ryterska ◽  
Maja Czerwińka-Rogowska ◽  
Dominika Jamioł-Milc ◽  
...  

(1) Introduction: Zonulin (ZO) has been proposed as a marker of intestinal permeability. Only a few studies have analyzed to date how diet influences the serum concentration of ZO among patients with non-alcoholic fatty liver disease (NAFLD). We performed a six-month dietetic intervention to evaluate the association between fiber intake and ZO concentration in 32 individuals with NAFLD. (2) Methods: Fiber content in the diet was estimated by Food Frequency Questionnaire (FFQ) and by analyzing 72-h nutritional diaries. ZO concentrations in serum were measured before and after the intervention by immunoenzymatic assay (ELISA). Fatty liver was quantified using the Hamaguchi score before and after the dietetic intervention. (3) Results: During the intervention, the dietary fiber intake increased from 19 g/day to the 29 g/day concomitant with an increase in the frequency of fiber consumption. All patients experienced significant (all p < 0.05) improvements in serum aspartate aminotransferase (AST), alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGTP) activities. We also detected decreased serum triglycerides (p = 0.036), homeostatic model assessment insulin resistance (HOMA-IR (p = 0.041) and insulin content (p = 0.34), and improvement of fatty liver status according to the Hamaguchi score (p = 0.009). ZO concentration in serum decreased by nearly 90% (7.335 ± 13.492 vs. 0.507 ± 0.762 ng/mL, p = 0.001) and correlated with the amount of dietary fiber intake (p = 0.043) as well as the degree of fatty liver (p = 0.037). (4) Conclusion: Increasing nutritional fiber results in reduced serum ZO levels, reduced liver enzymes and improved hepatic steatosis in patients with NAFLD, possibly by altering intestinal permeability. Increased dietary fiber intake should be recommended in patients with NAFLD.

2015 ◽  
Vol 9 (3) ◽  
pp. 141-147 ◽  
Author(s):  
Scarpellini E. ◽  
Lupo M. ◽  
Iegri C. ◽  
Gasbarrini A. ◽  
De Santis A. ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Amir Mohammad Kazemifar ◽  
Ali Akbar Shafikhani ◽  
Elaheh HajiNoormohammadi ◽  
Zahra Azarion ◽  
Aliakbar Hajiaghamohammadi

Abstract Background and objective The correlation between the eradication of Helicobacter pylori (HP) and non-alcoholic fatty liver disease (NAFLD) is a controversial one. The aim of this study is to investigate the effect of Helicobacter pylori treatment on liver function tests and lipid profiles and to compare its effects with exercise therapy and diet alone. Method This was a double-blind randomized clinical trial conducted at Qazvin University of Medical Sciences. One hundred patients with NAFLD having a positive test for urea breath testing were randomly assigned into one of the intervention and comparison groups. The diet and physical activity program were given to two groups of patients for 8 weeks, three sessions per week. In addition to the above therapy, the patients in the intervention group also received HP treatment for 2weeks. The data corresponding to anthropometric and clinical features before and after the intervention were collected in both groups and compared using appropriate statistical methods. Results After the treatment interventions, the variables of weight, BMI, blood glucose, triglyceride, AST, ALT, total cholesterol, and LDL-C were significantly decreased in both groups (p < .05). In the between-group comparisons, only ALT was significantly lower in the intervention group (HP) (p < .05). Conclusion Findings of this study showed that the eradication of Helicobacter pylori could significantly improve the ALT index, but it had no additional effect on changes in metabolic indicators. Trial registration Registration number: IRCT2015042020951N2 Name of trial registry: The study of treatment of Helicobacter pylori in improvement of non-alcoholic fatty liver disease The date of registration: 2015-05-12 Where the full trial protocol can be accessed: https://fa.irct.ir/trial/18489


2019 ◽  
Vol 25 (33) ◽  
pp. 4814-4834 ◽  
Author(s):  
Alberto Nicoletti ◽  
Francesca Romana Ponziani ◽  
Marco Biolato ◽  
Venanzio Valenza ◽  
Giuseppe Marrone ◽  
...  

2018 ◽  
Vol 154 (6) ◽  
pp. S-1176-S-1177
Author(s):  
Seema Nair Parvathy ◽  
Melanie D. Beaton ◽  
Jon Medding ◽  
Adam Rahman ◽  
Justin Tat-Ko ◽  
...  

2020 ◽  
Vol 12 (11) ◽  
pp. 1004-1019
Author(s):  
Joise Teixeira ◽  
Cláudio Augusto Marroni ◽  
Paula Rosales Zubiaurre ◽  
Ana Henz ◽  
Lais Faina ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document